The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults
Abstract
GH deficiency is associated with increased cardiovascular morbidity, which may be determined by alterations in vascular risk factors. We report the effect of partially treated hypopituitarism and subsequent GH replacement (mean dose, 0.2 IU/kg.week) on putative cardiovascular risk factors in 22 nondiabetic hypopituitary subjects in a 6-month, double blind, controlled study (active/placebo ratio, 11:11). All patients were subsequently treated with GH for a further 6 months. Total fat, percent body fat, and central fat were measured by dual energy x-ray absorptiometry. The hypopituitary patients had increased percent fat (P = 0.03) and central fat (P < 0.01) compared with body mass index-matched controls. Before GH treatment, fasting (total) and specific insulin positively correlated with body mass index (P = 0.02 and P < 0.001, respectively), waist/hip ratio (P = 0.05 and P = 0.01), and central fat (P = 0.03 and P = 0.003). Specific insulin and insulin sensitivity (IS), calculated by homeostatic model of assessment, were related to total fat (P < 0.001 and P = 0.02). GH treatment for 6 months led to a reduction in total fat (P < 0.02), percent fat (P = 0.002), central fat (P = 0.012), waist/hip ratio (P < 0.05), total cholesterol (P = 0.03), and apolipoprotein-B (P = 00001), as well as a decrease in the IS from 36.9% (range, 12-100%) to 25% (range, 2.5-55%; P = 0.0002). This was paralleled by a rise in fasting (total) and specific insulin (P = 0.016 and P = 0.002). The degree of correlation among indices of IS, body composition, and fat distribution increased after GH treatment. Fasting plasma glucose rose significantly, but was within the reference range. During 12 months of GH therapy, a significant increase in serum lipoprotein-(a) was observed (P < 0.05). Although GH has beneficial effects on central adiposity and lipid fractions, it is also associated with a decrease in IS; these effects may vary between individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Mazess, R., Barden, H., Bisek, J., & Hanson, J. (1990) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/51.6.1106 · Cited by 1,476
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Salomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326
BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS
Jørgensen, J. O. L., Thuesen, L., Ingemann-Hansen, T., Pedersen, S. A., Jørgensen, I., Skakkebaek, N. E., & Christiansen, J. S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92328-3 · Cited by 890
Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.
Bengtsson, B. A., Edén, S., Lönn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Tölli, J., Sjöström, L., & Isaksson, O. G. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432773 · Cited by 778
Markussis, V., Beshyah, S. A., Johnston, D. G., Fisher, C., Nicolaides, A. N., & Sharp, P. (1992) · The Lancet · doi:10.1016/0140-6736(92)92892-j · Cited by 390
Whitehead, H. M., Boreham, C., Mcllrath, E. M., Sheridan, B., Kennedy, L., Atkinson, A. B., & Madden, D. R. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02901.x · Cited by 377
SERUM-INSULIN IN ESSENTIAL HYPERTENSION AND IN PERIPHERAL VASCULAR DISEASE
Welborn, T. A., Breckenridge, A., Rubinstein, A. H., Dollery, C. T., & Fraser, T. R. (1966) · The Lancet · doi:10.1016/s0140-6736(66)92132-5 · Cited by 323
Rosen, T., Bosaeus, I., TöIli, J., Lindstedt, G., & Bengtsson, B. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00974.x · Cited by 256
Cuneo, R. C., Salomon, F., Watts, G. F., Hesp, R., & Sönksen, P. H. (1993) · Metabolism · doi:10.1016/0026-0495(93)90145-e · Cited by 253
Edén, S., Wiklund, O., Oscarsson, J., Rosén, T., & Bengtsson, B. A. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.2.296 · Cited by 211
Serum lipid levels in growth hormone-deficient men
de Boer, H., Blok, G. J., Voerman, H. J., Phillips, M., & Schouten, J. A. (1994) · Metabolism · doi:10.1016/0026-0495(94)90245-3 · Cited by 202
Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man
M�ller, N., Butler, P. C., Antsiferov, M. A., & Alberti, K. G. M. M. (1989) · Diabetologia · doi:10.1007/bf00505182 · Cited by 192
Hartman, M. L., Clayton, P. E., Johnson, M. L., Celniker, A., Perlman, A. J., Alberti, K. G., & Thorner, M. O. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116480 · Cited by 192
Donahue, L. R., & Beamer, W. G. (1993) · Journal of Endocrinology · doi:10.1677/joe.0.1360091 · Cited by 167
Russell-Jones, D. L., Watts, G. F., Welssberger, A. J., Naoumova, R. P., Myers, J., Thompson, G. R., & Sönksen, P. H. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02555.x · Cited by 145
Effect of growth hormone treatment on hormonal parameters, body composition and strength in athletes
Deyssig, R., Frisch, H., Blum, W. F., & Waldhör, T. (1993) · European Journal of Endocrinology · doi:10.1530/acta.0.1280313 · Cited by 128
ROSENBAUM, M. S., Gertner, J. M., & Leibel, R. L. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-6-1274 · Cited by 113
Møller, J., Jørgensen, J. O. L., Lauersen, T., Frystyk, J., Næraa, R. W., Øsrskov, H., & Christiansen, J. S. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02386.x · Cited by 70
The Assessment of Insulin, Glucose and Lipids in Ischemic Thrombotic Cerebrovascular Disease
Gertler, M. M., Leetma, H. E., Koutrouby, R. J., & Johnson, E. D. (1975) · Stroke · doi:10.1161/01.str.6.1.77 · Cited by 53
The first phase insulin response to intravenous glucose is highly reproducible
Rayman, G., Clark, P., Schneider, E., & Hales, C. N. (1990) · Diabetologia · doi:10.1007/bf00400209 · Cited by 35
Winocour, P. H., Kaluvya, S., Ramaiya, K. L., Brown, L., Millar, J. P., Farrer, M., Neil, H. A. W., Laker, M. F., & Alberti, K. G. M. M. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.3.393 · Cited by 33
Rosenbaum, M. S., Gertner, J. M., Gidfar, N., et al. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.1.1619004 · Cited by 20
Effects of growth hormone on low-density lipoprotein metabolism.
Angelin, B., Rudling, M., Olivecrona, H., et al. (1992) · PubMed · Cited by 8
6 Growth hormone disorders and secondary diabetes
Sharp, P. S., Beshyah, S., & Johnston, D. G. (1992) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80168-5 · Cited by 6
Cited by
Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
Møller, N., & Jørgensen, J. O. L. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0027 · Cited by 1,039
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
Lipshultz, S. E., Adams, M. J., Colan, S. D., Constine, L. S., Herman, E. H., Hsu, D. T., Hudson, M. M., Kremer, L. C., Landy, D. C., Miller, T. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182a88099 · Cited by 612
Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., Shalet, S. M., Vance, M. L., & for The Endocrine Society’s Clinical Guidelines Subcommittee (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2227 · Cited by 424
Metadata
- Authors
- Weaver, J. U.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1995-01-01
- Volume
- 80
- Issue
- 1
- Pages
- 153-159
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2021158913
- Cited by
- 282
- References
- 27
- FWCI
- 10.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.